KENDERA

Swiss trademark · 459376 · Word mark · In force

Register entry

Registration number
459376
Application number
08913/1998
Status
In force
Type
Word mark
Filed
Oct 29, 1998
Registered
Mar 9, 1999
Published
Apr 14, 1999
Protected until
Oct 29, 2028
Priority
03.09.1998 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, nämlich selektive Östrogenrezeptormodulatoren.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 4, 2018

    Renewed

    Published in Swissreg on 04.10.2018

  2. Aug 20, 2013

    Address changed

    Owner
    Watson Pharmaceuticals, Inc., 311 Bonnie Circle, Corona, CA 92880-2882, USA → Actavis, Inc., 400 Interpace Parkway, Parsippany, NJ 07054, USA

    Published in Swissreg on 20.08.2013

  3. Aug 20, 2013

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → B.M.G. Avocats, 8c, avenue de Champel,, Case postale 385, 1211 Genève 12

    Published in Swissreg on 20.08.2013

  4. Aug 20, 2008

    Renewed

    Published in Swissreg on 20.08.2008

  5. Aug 15, 2008

    Transferred

    Owner
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis (IN 46285), USA → Watson Pharmaceuticals, Inc., 311 Bonnie Circle, Corona, CA 92880-2882, USA

    Published in Swissreg on 15.08.2008

  6. Dec 3, 2007

    Agent’s address changed

    Representative
    E. Blum & Co., Patentanwälte, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 234 of 03.12.2007

  7. Apr 14, 1999

    Registered

    Published in the SOGC no. 71 of 14.04.1999

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.